Arch Venture Partners XII, 10% Owner: Prime Medicine PRME Buy · Filed 24/02/20

Trade details

Type: Insider buy
Amount: $20,000,000
Shares · price: 3,200,000 sh · $6.25 a share
Held after: 3,200,000 sh
Stock: Prime Medicine PRME
Person: Arch Venture Partners XII10% Owner
Trade date: 24/02/15
Filed: 24/02/20
Days to filing: 5 days

First buy since 2023

Insiders buying this week: 12 insiders

Prime Medicine trades, last 26 weeks

What else happened in Prime Medicine around then

Filed or reported within 30 days of the trade day · 24/01/16~24/03/16

Arch Venture Partners XII's recent trades

Arch Venture Partners XII10% Owner
BuySeaport Therapeutics
Buy
Seaport Therapeutics
SPTX
$19.8M
1,100,000 sh
$19.8M
Filed 05/04
Traded 05/04
Arch Venture Partners XII10% Owner
BuyNeumora Therapeutics
Buy
Neumora Therapeutics
NMRA
$5M
1,915,700 sh
$5M
Filed 25/10/29
Traded 25/10/27
Arch Venture Partners XII10% Owner
BuyPrime Medicine
Buy
Prime Medicine
PRME
$10M
3,030,300 sh
$10M
Filed 25/08/01
Traded 25/08/01
Arch Venture Partners XII10% Owner
BuyMetsera
Buy
Metsera
MTSR
$25.8M
1,432,224 sh
$25.8M
Filed 25/02/03
Traded 25/02/03
Arch Venture Partners XII10% Owner
BuyMetsera
Buy
Metsera
MTSR
$14.2M
789,998 sh
$14.2M
Filed 25/02/03
Traded 25/02/03